Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission
- PMID: 2834672
- DOI: 10.1016/0304-3940(88)90440-5
Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission
Abstract
The precise topographical changes in striatal D1 and D2 dopamine receptor density that occurred after chronic treatment with haloperidol or SCH 23390 or after 6-hydroxydopamine-induced lesion of the mesostriatal dopaminergic pathway have been studied autoradiographically in the rat. Repeated treatment with SCH 23390 (0.5 mg/kg i.p., 21 days) caused an almost similar increase in [3H]SCH 23390 binding sites in the different striatal subregions whereas lesion of the dopaminergic pathway was ineffective. Subacute administration of haloperidol (2 mg/kg i.p., 18 days) or lesion of dopaminergic afferents provoked an increase in [3H]spiperone binding which was restricted to the ventro- and dorsolateral striatal sectors.
Similar articles
-
Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.Neurosci Lett. 1987 Feb 24;74(2):180-6. doi: 10.1016/0304-3940(87)90146-7. Neurosci Lett. 1987. PMID: 2883609
-
6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.J Pharmacol Exp Ther. 1987 Jan;240(1):167-76. J Pharmacol Exp Ther. 1987. PMID: 3100767 Free PMC article.
-
Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.Brain Res. 1988 Mar 8;443(1-2):204-14. doi: 10.1016/0006-8993(88)91614-9. Brain Res. 1988. PMID: 2965958
-
Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies.Can J Psychol. 1990 Jun;44(2):253-75. doi: 10.1037/h0084241. Can J Psychol. 1990. PMID: 2116937 Review.
-
Receptor changes during chronic dopaminergic stimulation.J Neural Transm Suppl. 1988;27:161-75. doi: 10.1007/978-3-7091-8954-2_14. J Neural Transm Suppl. 1988. PMID: 2900291 Review.
Cited by
-
Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease.Sci Rep. 2017 Jan 30;7:41589. doi: 10.1038/srep41589. Sci Rep. 2017. PMID: 28134302 Free PMC article.
-
Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.J Neurosci. 2001 Jun 15;21(12):4390-9. doi: 10.1523/JNEUROSCI.21-12-04390.2001. J Neurosci. 2001. PMID: 11404425 Free PMC article.
-
Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.Mov Disord. 2017 Apr;32(4):538-548. doi: 10.1002/mds.26955. Epub 2017 Mar 3. Mov Disord. 2017. PMID: 28256010 Free PMC article.
-
Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.Exp Brain Res. 1990;83(1):85-95. doi: 10.1007/BF00232196. Exp Brain Res. 1990. PMID: 1981564
-
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.Front Behav Neurosci. 2011 Oct 24;5:71. doi: 10.3389/fnbeh.2011.00071. eCollection 2011. Front Behav Neurosci. 2011. PMID: 22028687 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous